AnalyzeDirect

Loss of phosphodiesterase 10A signalling is associated with progression and severity in patients with Parkinson’s disease

Niccolini F, Foltynie T, Reis Marques T, Searle G, Natesan S, Kapur S, Rabiner E, Gunn R, Piccini P, Politis M. Loss of phosphodiesterase 10A signalling is associated with progression and severity in patients with Parkinson’s disease. Abstract. J Nucl Med. May 2015;56(supplement 3):31. Full Text – Open Access Publication Date May 2015 How Analyze…